Skip to content

A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers

Status
Not yet recruiting
Phases
Phase 1
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2025-523601-16-00
Enrollment
126
Registered
2026-09-08
Start date
Unknown
Completion date
Unknown
Last updated
2026-09-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diffuse Large B-Cell Follicular Lymphoma, Lymphoma, Non-Hodgkin's Lymphoma

Interventions

None listed

Sponsors

Eli Lilly & Co.
Lead SponsorINDUSTRY

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Outcome results

None listed

Source: EU CTIS · Data processed: Sep 10, 2026